Oncotarget Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell Impact Journals, the publisher of Oncotarget, is once again proudly sponsoring the Open Access Team... read more June 10, 2025
Oncotarget Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model There are more than 13,000 new cases of malignant brain tumors diagnosed each year... read more June 4, 2025
Oncotarget Engineered Proteins Show Promise in Stopping Glioblastoma Invasion The results demonstrated that the minimal TIMP variants, mTC1, and mTC3, effectively inhibit MMP activity... read more May 21, 2025
Oncotarget Panitumumab and Low-Dose Capecitabine: A Promising Maintenance Therapy for Metastatic Colorectal Cancer Considerations around maintenance therapy are of particular importance when drugs associated with cumulative neurotoxicity like... read more May 7, 2025
Oncotarget New Insights into p53: A Powerful Gene’s Role in Cancer Therapy studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to... read more April 22, 2025
Oncotarget Targeting SETDB1: A New Strategy for Treating Osteosarcoma Osteosarcoma is characterized by a complex genetic profile that leads to significant genetic instability, which... read more April 9, 2025
Oncotarget When the Cure Becomes the Cause: A Rare Case of Cancer from Donor Cells Donor cell-derived hematologic neoplasms are extremely rare complications that arise after hematopoietic stem cell transplantation."... read more March 26, 2025
Oncotarget A Rare Genetic Shift That Helped Lung Cancer Evade Treatment This case adds to the literature on bypass signaling as a mechanism of resistance to... read more March 12, 2025
Oncotarget How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the... read more February 26, 2025
Oncotarget A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1 The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more January 28, 2025